Assertio Therapeutics Inc. (DepoMed Inc.) (ASRT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

100 SOUTH SAUNDERS RD LAKE FOREST, IL 60045

DepoMed is a pharmaceutical company focused on neurology, pain and other diseases of the central nervous system. Gralise (gabapentin) is Co.'s formulation of gabapentin for the management of postherpetic neuralgia. Co. also provides Glumetza (metformin hydrochloride extended release tablets), a treatment for adults with type two diabetes. In addition, Co. has two product candidates in clinical development, DM-1992 for Parkinson's disease and Serada for menopausal hot flashes. Additionally, Co. has a number of other license and development arrangements associated with its Acuform gastroretentive drug delivery technology.

Data based on most recent fiscal year report
Market Cap82.667 Million Shares Outstanding63.59 Million Avg Volume1.894 Million
1-Yr BETA vs S&P TR2.138 Current Ratio0.74 Quick Ratio0.7
View SEC Filings from ASRT instead.

View recent insider trading info

Funds Holding ASRT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ASRT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

43.2 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TYREE JAMES L

  • Director
5,345 2020-01-13 1

TANG KEVIN C

TANG CAPITAL PARTNERS LP

TANG CAPITAL MANAGEMENT LLC

  • Director
  • 10% Owner
7,910,575 2020-01-09 0

SCHOENECK JAMES A INTERIM PRESIDENT

  • Officer
  • Director
22,422 2020-01-06 0

ANIDO VICENTE JR CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
205,881 2019-12-31 0

FOGARTY JAMES P

  • Director
13,356 2019-12-31 1

HIGGINS ARTHUR J

  • Director
19,070 2019-12-31 7

PEISERT DANIEL A. SVP AND CFO

  • Officer
80,783 2019-12-01 10

LAVIGNE LOUIS J JR

  • Director
248,697 2019-11-29 1

STAPLE PETER D

  • Director
221,780 2019-11-11 2

WHEADON DAVID E.

  • Director
0 2019-09-28 2

BUKOFZER STAN SVP, CHF SCITFC & TECH OFFICER

  • Officer
26,936 2019-08-13 4

SAKS SAMUEL R

  • Director
0 2019-06-20 0

MCKEE WILLIAM

  • Director
0 2019-06-19 2

DAWES KAREN A

  • Director
117,034 2019-06-17 2

DONENBERG PHILLIP B.

  • Director
0 2019-06-11 0

GALEOTA JAMES JR

  • Director
0 2019-06-11 2

SAVAGE ROBERT G.

199,869 2019-05-14 0

SMITH CRAIG R

  • Director
46,469 2019-04-18 0

MASON HEATHER L

  • Director
0 2019-02-18 2

MOLINELLI GAVIN

  • Director
No longer subject to file 2018-12-07 0

GOSLING MATTHEW M SVP, GENERAL COUNSEL

  • Officer
0 2018-05-11 0

MORETTI AUGUST J CHIEF FINANCIAL OFFICER & SVP

  • Officer
74,447 2018-03-31 0

VETTICADEN SANTOSH SVP, CHIEF MEDICAL OFFICER ***

  • Officer
0 2018-02-06 0

VARGAS THADD M SVP, BUSINESS DEVELOPMENT

  • Officer
0 2017-06-13 0

SRINIVAS G. RAO SVP AND CHIEF MEDICAL OFFICER

  • Officer
19,527 2017-04-02 0

ZENOFF DAVID B

  • Director
93,999 2017-02-21 0

STERN JULIAN N

  • Director
0 2016-06-08 0

SHIVELY RICHARD SCOTT SVP & CHIEF COMMERCIAL OFFICER

  • Officer
4,290 2016-04-02 0

BURRILL STEVEN

  • Director
0 2013-12-10 0

SWEENEY MICHAEL MD CMO AND VP, R&D

  • Officer
9,084 2013-12-02 0

CAMERON TAMMY VP, FINANCE

  • Officer
0 2011-09-01 0

PELZEL CARL A PRESIDENT AND CEO

  • Officer
  • Director
0 2011-01-14 0

SHELL JOHN N VP, OPERATIONS

  • Officer
0 2008-01-25 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HIGGINS ARTHUR J - Director - Officer DIRECTOR, PRESIDENT AND CEO

2019-12-01 M 34,860 a 147,739 315,526.00 direct

PEISERT DANIEL A. - Officer SVP AND CFO

2019-12-01 M 8,359 d 16,717 80,783.00 direct

HIGGINS ARTHUR J - Director - Officer DIRECTOR, PRESIDENT AND CEO

2019-12-01 M 34,860 d 34,860 315,526.00 direct

PEISERT DANIEL A. - Officer SVP AND CFO

2019-12-01 F 2,449 $0.76 d 80,783 80,783.00 direct

HIGGINS ARTHUR J - Director - Officer DIRECTOR, PRESIDENT AND CEO

2019-12-01 F 10,213 $0.76 d 137,526 315,526.00 direct

PEISERT DANIEL A. - Officer SVP AND CFO

2019-12-01 M 8,359 a 83,232 80,783.00 direct
Click here to report any possible errors with this stock listing.

Elevate your investments